




Searching News Database: Vidaza
HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
HSMN NewsFeed - 5 Nov 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
HSMN NewsFeed - 21 Aug 2008
VIDAZA(R) Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
VIDAZA(R) Receives Expanded FDA Approval to Include Overall Survival in Higher-Risk MDS
HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
HSMN NewsFeed - 13 Jun 2008
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
HSMN NewsFeed - 17 Oct 2007
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
HSMN NewsFeed - 29 Aug 2007
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
HSMN NewsFeed - 22 Mar 2007
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
Additional Data from Satraplatin SPARC Phase 3 Trial Presented at European Association of Urology Congress
HSMN NewsFeed - 29 Jan 2007
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
HSMN NewsFeed - 11 Dec 2006
New Data Validate Vidaza(R) Response Rates in MDS and Report Results in AML
New Data Validate Vidaza(R) Response Rates in MDS and Report Results in AML
HSMN NewsFeed - 21 Nov 2006
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
HSMN NewsFeed - 1 Nov 2006
Pharmion Corporation Announces Enrollment of First Patient Into Vidaza(R) Patient Registry
Pharmion Corporation Announces Enrollment of First Patient Into Vidaza(R) Patient Registry
HSMN NewsFeed - 25 Apr 2006
Independent Data Monitoring Board Recommends That Satraplatin Phase 3 Trial Continue as Planned
Independent Data Monitoring Board Recommends That Satraplatin Phase 3 Trial Continue as Planned
HSMN NewsFeed - 30 Mar 2006
Pharmion Corporation Announces Submission of Vidaza NDA Supplement for IV Administration
Pharmion Corporation Announces Submission of Vidaza NDA Supplement for IV Administration
Additional items found! 9

Members Archive contains
9 additional stories matching:
Vidaza
(Password required)
Vidaza
(Password required)